MEVAC is an American Egyptian Animal Health Vaccines leading global provider of innovative animal health solutions established in 2011

MEVAC has built a strong reputation for excellence in research and development, manufacturing,and distribution of high-quality vaccines for Poultry, Ruminant, and Aquaculture.

With a robust infrastructure comprising four state-of-the-art production lines and four manufacturing sites, we possess the capacity to meet the growing demand for animal health vaccines. Our research and development excellence centers drive innovation projects, allowing MEVAC to develop cutting-edge vaccines that address the evolving needs of the global animal health industry.

At MEVAC, we are committed to upholding the highest standards of quality. Our facilities are GMP- Accredited, ensuring that our vaccines meet stringent regulatory requirements. We employ a team of more than 450 dedicated professionals representing seven nationalities, who work tirelessly to develop and deliver products that safeguard animal health and welfare.

MEVAC has 3 Headquarters In , Egypt , UAE & KSA,.We have a strong presence in key markets. Our extensive distribution network enables us to export our products to over 30 countries worldwide in 2023 & is planned to reach 90 Countries by 2027, supporting the health and well-being of animals across the globe.

MEVAC is a market leader in Avian Influenza vaccines (H5N1 and H5N8) market (MEFLUVAC H5 range)